Tuesday, 27 October 2020

Oxford vaccine immune response triggers hopes

Coronavirus vaccine being developed by AstraZeneca and Oxford University has successfully triggered a strong immune response among both young and old. The announcement by AstraZeneca has triggered hopes across countries ravaged by the Covid-19 pandemic. Meanwhile in India, Bharat Biotech and ICMR will be entering Phase III clinical trials of the indigenous vaccine, Covaxin.


No comments:

Featured Post

Did humpty dumpty really have a great fall ?

The Hindenburg report, released on 24th Jan, 2023 had the intended outcome. The short seller shaved off $ 100 Billion Dollars or more of Ada...